The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions
Synaptic gene conditions, i.e., “synaptopathies,” involve disruption to genes expressed at the synapse and account for between 0.5 and 2% of autism cases. They provide a unique entry point to understanding the molecular and biological mechanisms underpinning autism-related phenotypes. Phelan-McDermi...
Main Authors: | Jennifer Cooke, Ciara J. Molloy, Antonia San José Cáceres, Thomas Dinneen, Thomas Bourgeron, Declan Murphy, Louise Gallagher, Eva Loth |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.806990/full |
Similar Items
-
Dissecting the Heterogeneity of Autism: Focus on Phelan-McDermid Syndrome
by: C. Lamschtein, et al.
Published: (2022-06-01) -
Characterisation of the clinical phenotype in Phelan-McDermid syndrome
by: Mónica Burdeus-Olavarrieta, et al.
Published: (2021-07-01) -
Sensory Reactivity Phenotype in Phelan–McDermid Syndrome Is Distinct from Idiopathic ASD
by: Teresa Tavassoli, et al.
Published: (2021-06-01) -
Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
by: Teresa M. Kohlenberg, et al.
Published: (2020-02-01) -
Phelan-McDermid syndrome: a classification system after 30 years of experience
by: Katy Phelan, et al.
Published: (2022-01-01)